NeuroSense Therapeutics Ltd. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
NeuroSense Therapeutics Ltd. (NRSN) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $413.00 thousand for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-30.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2024-09-30
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|
| 2024-06-30 | $413.00K 6-K · filed 2024-09-30 | |
| 2023-12-31 | $1.70M 6-K · filed 2024-06-17 | |
| 2023-06-30 | $1.19M 6-K · filed 2024-09-30 | |
| 2022-12-31 | $1.73M 6-K · filed 2024-06-17 | |
| 2021-12-31 | $2.12M 6-K · filed 2024-06-17 |